tiprankstipranks
Trending News
More News >
BillionToOne, Inc. Class A (BLLN)
NASDAQ:BLLN
US Market

Compare BillionToOne, Inc. Class A (BLLN) vs. Competitors

Compare
96 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BillionToOne, Inc. Class A
$104.66
$4.32B
-297.49
5 Buy
2 Hold
0 Sell
Moderate Buy
Myriad Genetics
$6.04
$569.54M
-1.39
-54.07%
3 Buy
2 Hold
1 Sell
Moderate Buy
Natera
$240.34
$33.09B
-105.22
41.09%
15 Buy
2 Hold
0 Sell
Strong Buy
Fulgent Genetics
$28.65
$864.62M
69.43%
1 Buy
1 Hold
0 Sell
Moderate Buy
Guardant Health
$111.98
$14.05B
-34.85
198.61%
18 Buy
1 Hold
0 Sell
Strong Buy
GRAIL Inc
$97.44
$4.08B
-8.39
454.27%
2 Buy
1 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BLLN
BillionToOne, Inc. Class A
MYGN
Myriad Genetics
6.04
-6.35
-51.25%
NTRA
Natera
240.34
81.98
51.77%
FLGT
Fulgent Genetics
28.65
11.55
67.54%
GH
Guardant Health
111.98
75.32
205.46%
GRAL
GRAIL Inc
97.44
80.02
459.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts